CNBC Investment News
Expert Analysis, Investment Tools, Stock Screeners, and Financial Strategy Information.
Updated: 4 hours 7 min ago
Jim Cramer spoke with JJ Bienaimé for more on the company's newest drug that treats a very rare disease.
Jim Cramer looks ahead to a tidal wave of earnings and seeks out buying opportunities.
Infrastructure stocks got a big boost after Trump's election, but the run is "not even beginning," Mario Gabelli says.
Wall Street has raised its expectations for Amazon and Google's parent company, Alphabet.
"We have a very strong product roadmap both in hardware and in software," CEO Nick Woodman says.
The stock opened trading 10 percent lower at $13.50 a share, below its IPO price of $15.
Credit Suisse reiterates its outperform rating on Apple into the company's earnings report next week.
Time Inc said on Friday it had evaluated potential offers but decided to pursue its own strategic plan, sending its shares tumbling more than 20 percent.
Capacity is much more of a concern for ETF issuers than the much-talked-about myth of ETF liquidity.
The noted economist says stormy days could be ahead for the economy and the market.
Names on the move ahead of the open.
Pacific Crest lowers its rating on Amazon to sector weight, citing increasing competition and "moderating" growth trends.
A daily look at the morning's key financial stories.
Even after a huge rally, the Wizard of Wharton remains strikingly bullish on the market.
One trader says there is more pain to come for oil.
Analysts upgraded their price targets and earnings forecast for Samsung in 2017, prompting shares to rally.
Jim Cramer explains why these top tech stocks continue to draw investors.
Activist hedge fund manager Dan Loeb told investors he doesn't plan on missing out on the Trump trade.
This might be a situation where you buy the rumor and you sell the news, Jack Bouroudjian told CNBC.